
---
title: '国金证券：医疗板块投资仍然聚焦于疫情应对需求、消费医疗和院内诊疗'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=3570'
author: 证券时报网
comments: false
date: Fri, 09 Apr 2021 11:05:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=3570'
---

<div>   
<p style="text-align: left;"><font color="#050f51">证券时报网讯，国金证券指出，</font>2021年医疗板块投资仍然聚焦于三大主线：疫情应对需求、消费医疗和院内诊疗，每条主线均有值得把握的重点投资机会。疫情应对需求：仍是重要主线，看好疫苗放量+防护检测持续性需求。消费医疗：走出疫情影响，成长确定性高扰动因素少，重点看好生长激素、常规疫苗、连锁医疗服务、医疗美容、血液制品等细分赛道投资机会。院内诊疗：常规IVD的恢复是机遇，高值耗材靠创新谋出路，重点看好化学发光、常规POCT等体外诊断优势赛道，以及具备较强创新特色、医保控费风险小的高值耗材品种。重点公司：<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300601" code="300601">康泰生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300122" code="300122">智飞生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000661" code="000661">长春高新</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS603658" code="603658">安图生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300760" code="300760">迈瑞医疗</a>等。</p>
                  
</div>
            